DementiaNCT04507633
ROMA (Reminiscence, Reality Orientation, Music and Art ) Therapy, Cognition, Depression and Behavioral Problems in the Population With Dementia
A study testing ROMA therapy(reminiacence therpy, orientation, music, and art) in people with Dementia, run by Taipei Medical University at 1 site in Taiwan.
Trial summary
This study aimed to conduct a randomized controlled trial to examine the effectiveness of ROMA therapy( Reminiscence, Reality Orientation, Music, and Art) on improving cognitive function, behavioral and psychological symptoms in population with dementia. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Dementia
- What is being tested?
- ROMA therapy(reminiacence therpy, orientation, music, and art)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 45 participants
- Where
- 1 siteTaiwan
- Study dates
- 25 Aug 2020to 31 Jul 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Been diagnosed as mild to moderate dementia and CDR score between 0.5~2
- can communicate in Chinese or Taiwanese
- without visual or auditory impairment after equipping assist devices
Who cannot join
- severe dementia and Clinical Dementia Rating (CDR) score more than 2 points
- functional dependence
- incapable of expressing their feelings
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of ROMA Therapy on Improving Cognitive Functions, Depressive Symptoms and Behavioral Problems in the Population With Dementia
This study aimed to conduct a randomized controlled trial to examine the effectiveness of ROMA therapy( Reminiscence, Reality Orientation, Music, and Art) on improving cognitive function, behavioral and psychological symptoms in population with dementia. The hypotheis of this study is that these patients with dementia receiving ROMA therapy featuring reminiscence, reality orientation, music, and art would improve their cognition, depressive symptoms, and behavioral symptoms.
Read the detailed description
This study aimed to conduct a randomized controlled trial to examine the effectiveness of ROMA therapy( Reminiscence, Reality Orientation, Music, and Art) on improving cognitive function, behavioral and psychological symptoms in demented population. A total of 60 patients with mild to moderate dementia will be recruited and randomly assigned to two groups: experimental group and control group. The experimental group will undergo ROMA therapy with a 60 minute per week for eight weeks. The control group will receive three times ROMA therapy after completing outcome measurements. Two groups will receive questionnaire interview at pre-test, post-test, and at 4 weeks after intervention. The measurements comprises: Short Portable Mental Status Questionnaire(SPMSQ), Cornell Scale for Depression in Dementia(CSDD),and Neuropsychiatric Inventory-Questionnaire(NPI-Q). By identifying the effectiveness of ROMA therapy, suitable intervention can be suggested for those demented population to improve cognitive function, behavioral and psychological symptoms.
- Conditions
- Dementia
- Being tested
- ROMA therapy(reminiacence therpy, orientation, music, and art)
- Medical subject headings
- Dementia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ROMA therapy(reminiacence therpy, orientation, music, and art)Behavioural
An intervention comprising reminiscence of annual festivals, orientation, and familiar music listening and singing, and animation interaction to improve cognitive functions, depressive symptoms and behaviors problems.
| Study group | Role | What they receive |
|---|---|---|
| ROMA therapy | Experimental | ROMA therapy combines four elements including reminiscence, reality orientation, music, and art in the intervention. Receives: Behavioral: ROMA therapy(reminiacence therpy, orientation, music, and art) |
| control group | No intervention | usual care |
What is being measured
The primary outcome is the main question the study is designed to answer.
cognitive functions
Short Portable Mental Status Questionnaire(SPMSQ)
Measured: cognitive functions at baseline
cognitive functions
Short Portable Mental Status Questionnaire(SPMSQ)
Measured: cognitive functions after the completion of intervention
cognitive functions
Short Portable Mental Status Questionnaire(SPMSQ)
Measured: cognitive functions at 4 weeks after the completion of intervention
depressive symptoms
Cornell Scale for Depression in Dementia(CSDD)
Measured: depressive symptoms at baseline
depressive symptoms
Cornell Scale for Depression in Dementia(CSDD)
Measured: depressive symptoms after the completion of intervention
depressive symptoms
Cornell Scale for Depression in Dementia(CSDD)
Measured: depressive symptoms at 4 weeks after the completion of intervention
behavioral problems
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
Measured: behavioral problems at baseline
behavioral problems
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
Measured: behavioral problems after the completion of intervention
behavioral problems
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
Measured: behavioral problems at 4 weeks after the completion of intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Aug 2020
- Study start25 Aug 2020
- Primary completion30 Jul 2021
- Study completion31 Jul 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for DementiaStudies of the same condition, open and under way.
- More trials run by Taipei Medical UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Care provider, Outcomes assessor
- Enrolment
- 45 participants (actual)
Sponsor and investigators
- Lead sponsor
- Taipei Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Huang, Hui-Chuan, Taipei Medical University
- Investigators
- Hui-Chuan Huang, PhD, Principal investigator, School of Nursing, Taipei Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04507633
- Sponsor's protocol ID
- N202005108
- Status last verified
- Mar 2022
- First submitted
- 25 Jul 2020
- Last updated
- 21 Mar 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Tz-Han L, Wan-Ru W, I-Hui C, Hui-Chuan H. Reminiscence music intervention on cognitive, depressive, and behavioral symptoms in older adults with dementia. Geriatr Nurs. 2023 Jan-Feb;49:127-132. doi: 10.1016/j.gerinurse.2022.11.014. Epub 2022 Dec 8.
PubMed 36495795
Study at a glance
From the registry record, last updated by the sponsor on 21 Mar 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of ROMA Therapy on Improving Cognitive Functions, Depressive Symptoms and Behavioral Problems in the Population With Dementia
- ClinicalTrials.gov ID
- NCT04507633
- Acronym / sponsor ID
- N202005108
- Conditions
- Dementia
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 45 participants (actual)
- Lead sponsor
- Taipei Medical UniversityUniversity, hospital or other
- Study start
- 25 Aug 2020 (actual)
- Primary completion
- 30 Jul 2021 (actual)
- Study completion
- 31 Jul 2021 (actual)
- First posted
- 11 Aug 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aimed to conduct a randomized controlled trial to examine the effectiveness of ROMA therapy( Reminiscence, Reality Orientation, Music, and Art) on improving cognitive function, behavioral and psychological symptoms in population with dementia. The hypotheis of this study is that these patients with dementia receiving ROMA therapy featuring reminiscence, reality orientation, music, and art would improve their cognition, depressive symptoms, and behavioral symptoms.
Detailed description
This study aimed to conduct a randomized controlled trial to examine the effectiveness of ROMA therapy( Reminiscence, Reality Orientation, Music, and Art) on improving cognitive function, behavioral and psychological symptoms in demented population. A total of 60 patients with mild to moderate dementia will be recruited and randomly assigned to two groups: experimental group and control group. The experimental group will undergo ROMA therapy with a 60 minute per week for eight weeks. The control group will receive three times ROMA therapy after completing outcome measurements. Two groups will receive questionnaire interview at pre-test, post-test, and at 4 weeks after intervention. The measurements comprises: Short Portable Mental Status Questionnaire(SPMSQ), Cornell Scale for Depression in Dementia(CSDD),and Neuropsychiatric Inventory-Questionnaire(NPI-Q). By identifying the effectiveness of ROMA therapy, suitable intervention can be suggested for those demented population to improve cognitive function, behavioral and psychological symptoms.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, care provider, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| ROMA therapy | Experimental | Behavioral: ROMA therapy(reminiacence therpy, orientation, music, and art)ROMA therapy combines four elements including reminiscence, reality orientation, music, and art in the intervention. |
| control group | No intervention | –usual care |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (3 listed)
- Been diagnosed as mild to moderate dementia and CDR score between 0.5~2
- can communicate in Chinese or Taiwanese
- without visual or auditory impairment after equipping assist devices
Key exclusion criteria (3 listed)
- severe dementia and Clinical Dementia Rating (CDR) score more than 2 points
- functional dependence
- incapable of expressing their feelings
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ROMA therapy(reminiacence therpy, orientation, music, and art)An intervention comprising reminiscence of annual festivals, orientation, and familiar music listening and singing, and animation interaction to improve cognitive functions, depressive symptoms and behaviors problems. | Behavioural | ROMA therapy |
Primary outcome
cognitive functions
Time frame: cognitive functions at baseline
Short Portable Mental Status Questionnaire(SPMSQ)
cognitive functions
Time frame: cognitive functions after the completion of intervention
Short Portable Mental Status Questionnaire(SPMSQ)
cognitive functions
Time frame: cognitive functions at 4 weeks after the completion of intervention
Short Portable Mental Status Questionnaire(SPMSQ)
depressive symptoms
Time frame: depressive symptoms at baseline
Cornell Scale for Depression in Dementia(CSDD)
depressive symptoms
Time frame: depressive symptoms after the completion of intervention
Cornell Scale for Depression in Dementia(CSDD)
depressive symptoms
Time frame: depressive symptoms at 4 weeks after the completion of intervention
Cornell Scale for Depression in Dementia(CSDD)
behavioral problems
Time frame: behavioral problems at baseline
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
behavioral problems
Time frame: behavioral problems after the completion of intervention
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
behavioral problems
Time frame: behavioral problems at 4 weeks after the completion of intervention
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Mar 2022.
- Derived from this study: PubMed 36495795Tz-Han L, Wan-Ru W, I-Hui C, Hui-Chuan H. Reminiscence music intervention on cognitive, depressive, and behavioral symptoms in older adults with dementia. Geriatr Nurs. 2023 Jan-Feb;49:127-132. doi: 10.1016/j.gerinurse.2022.11.014. Epub 2022 Dec 8.
- Individual participant dataSharing planned: No
Related trials for Dementia
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Not yet recruiting
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease
Alzheimer's Disease
RecruitingObservational study
Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study
Alzheimer's Disease (AD)
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hui-Chuan Huang, PhD principal investigator
School of Nursing, Taipei Medical University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ROMA therapy(reminiacence therpy, orientation, music, and art) in people with Dementia, run by Taipei Medical University at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
cognitive functions (time frame: cognitive functions at baseline). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04507633, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2022.